As of 2026-03-29, 第四代喹若酮类口服药物's data on the DeepSeek platform in the 抗生素 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
第四代喹若酮类口服药物's Mention Rate is 0.00%, lower than 0.6% of competitors
第四代喹若酮类口服药物's First Mention is 0.00%, lower than 0.9% of competitors
第四代喹若酮类口服药物's Preferred Rate is 0.00%, lower than 100.0% of competitors
第四代喹若酮类口服药物's Positive Rate is 0.00%, lower than 8.9% of competitors
第四代喹若酮类口服药物's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 第第四代喹若酮类口服药物 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
